Product correctly added to cart.

discount label
Selumetinib
View 3D

Targetmol logo

Selumetinib

CAS: 606143-52-6

Ref. TM-T6218

1g
276.00 €
25mg
51.00 €
50mg
68.00 €
100mg
88.00 €
200mg
122.00 €
500mg
185.00 €
Estimated delivery in United States, on Thursday 16 Jan 2025

Product Information

Name:
Selumetinib
Synonyms:
  • AZD6244
  • ARRY-142886
  • 1H-Benzimidazole-6-carboxamide, 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-
  • 5-(4-Bromo-2-chlorophenylamino)-4-fluoro-1-methyl-1H-benzimidazole-6-carbohydroxamic acid 2-hydroxyethyl ester
  • 5-[(4-Bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide
  • 6-(4-Bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide
  • Arry-142886
  • Azd 6244
  • Azd-6224
  • Azd6244
  • See more synonyms
  • G 00039805
  • Koselugo
  • NSC 741O78
  • Zd-6244
Description:

Selumetinib (AZD6244) is a selectivity and non-ATP-competitive MEK1/2 inhibitor. Selumetinib has antitumor activity. Cost-effective and quality-assured.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
457.68
Formula:
C17H15BrClFN4O3
Purity:
98.1% - 99.46%
Color/Form:
White Or Pale White Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T6218 Selumetinib

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".